←Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC Advances
Jean-Charles Soria
MD, PhD
🏢Gustave Roussy / Paris-Saclay University🌐France
Professor of Medical Oncology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jean-Charles Soria led pivotal EGFR TKI trials and has contributed to squamous NSCLC drug development. His work explores FGFR and other actionable targets in squamous tumors. He has held leadership roles across industry and academic drug development.
Share:
🧪Research Fields 研究领域
Early-phase trials
EGFR inhibitors
Squamous NSCLC
FGFR targets
Drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jean-Charles Soria 的研究动态
Follow Jean-Charles Soria's research updates
留下邮箱，当我们发布与 Jean-Charles Soria（Gustave Roussy / Paris-Saclay University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment